EVELYNA VARTANIANS: Open Payments
NPI 1750957031 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,276 in 92 payments from 40 companies in 2025. Trend: 2023 $0 · 2024 $3,556 · 2025 $2,276
Food & beverage: $2,276
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $267 |
| E.R. Squibb & Sons, L.L.C. | 8 | $140 |
| Daiichi Sankyo Inc. | 5 | $121 |
| AstraZeneca Pharmaceuticals LP | 5 | $119 |
| Novartis Pharmaceuticals Corporation | 5 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $113 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $112 |
| Janssen Biotech, Inc. | 5 | $106 |
| PFIZER INC. | 3 | $99 |
| Incyte Corporation | 3 | $81 |
Products named: KEYTRUDA, Enhertu, FRUZAQLA, CARVYKTI, OPDIVO, TIVDAK, Lenvima, VERZENIO.
Industry payments across CA — which companies pay providers there.
